Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin-Fa Wang

Showing results (401-410 of 433) with videos related to

Pageof 44
Sort By:
Science Advances|July 26, 2023
Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivorWan Ni Chia, Chee Wah Tan, Aaron Wai Kit Tan, et al.
Ebiomedicine|April 12, 2021
Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational studyBarnaby E Young, Wycliffe E Wei, Siew-Wai Fong, et al.
JAMA|March 4, 2020
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in SingaporeBarnaby Edward Young, Sean Wei Xiang Ong, Shirin Kalimuddin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2022
Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical TrialXuan Ying Poh, Chee Wah Tan, I Russel Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2020
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) SeverityBarnaby E Young, Sean W X Ong, Lisa F P Ng, et al.
The Journal of Experimental Medicine|March 1, 2021
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infectionNina Le Bert, Hannah E Clapham, Anthony T Tan, et al.
BMC Biology|November 27, 2024
Serological evidence of sarbecovirus exposure along Sunda pangolin trafficking pathwaysBrian M Worthington, Portia Y-H Wong, Kishoree K Kumaree, et al.
Lancet (London, England)|August 22, 2020
Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort studyBarnaby E Young, Siew-Wai Fong, Yi-Hao Chan, et al.
Vaccine|September 6, 2024
Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trialXuan Ying Poh, Anthony Torres-Ruesta, Terence Yoong, et al.
Ebiomedicine|August 13, 2024
First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trialXuan Ying Poh, I Russel Lee, Chee Wah Tan, et al.
Pageof 44

Showing results (401-410 of 433) with videos related to

Sort By:
Pageof 44
Science Advances|July 26, 2023
Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivorWan Ni Chia, Chee Wah Tan, Aaron Wai Kit Tan, et al.
Ebiomedicine|April 12, 2021
Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational studyBarnaby E Young, Wycliffe E Wei, Siew-Wai Fong, et al.
JAMA|March 4, 2020
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in SingaporeBarnaby Edward Young, Sean Wei Xiang Ong, Shirin Kalimuddin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2022
Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical TrialXuan Ying Poh, Chee Wah Tan, I Russel Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2020
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) SeverityBarnaby E Young, Sean W X Ong, Lisa F P Ng, et al.
The Journal of Experimental Medicine|March 1, 2021
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infectionNina Le Bert, Hannah E Clapham, Anthony T Tan, et al.
BMC Biology|November 27, 2024
Serological evidence of sarbecovirus exposure along Sunda pangolin trafficking pathwaysBrian M Worthington, Portia Y-H Wong, Kishoree K Kumaree, et al.
Lancet (London, England)|August 22, 2020
Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort studyBarnaby E Young, Siew-Wai Fong, Yi-Hao Chan, et al.
Vaccine|September 6, 2024
Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trialXuan Ying Poh, Anthony Torres-Ruesta, Terence Yoong, et al.
Ebiomedicine|August 13, 2024
First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trialXuan Ying Poh, I Russel Lee, Chee Wah Tan, et al.
Pageof 44